Bedrocan is the world’s most experienced producer of pharmaceutical-grade, standardised, full-bud medicinal cannabis. Active Pharmaceutical Ingredients The medicinal cannabis varieties that Bedrocan produces are used as Active Pharmaceutical Ingredients (API’s). Standardised pharmaceutical-grade medicinal cannabis is the most suitable raw material for the production of THC or CBD isolates, full-spectrum cannabis oil or CBD-oil, ointments and other cannabis-based medicinal products (CBMP’s). It’s also used as Investigational Medical Product. Today, Bedrocan produces five pharmaceutical-grade cannabis products or plant varieties for medicine development, patients and clinical use. The five products currently available are Bedrocan®, Bedrobinol®, Bediol®, Bedica® and Bedrolite®. These products are delivered to pharmaceutical manufacturers by the Dutch Office of Medicinal Cannabis (OMC). The OMC also makes sure that patients with a doctor´s prescription can obtain this medicinal cannabis at Dutch pharmacies. Patient focus and research Bedrocan strives to bridge the gap between patients' needs for cannabis and the quality standards of modern medicine. We do this through an active research program and a commitment to sharing our knowledge through scientific publication. We believe cannabis can, and should, meet all of the existing regulations for medicines. Availability/Supply In the Netherlands, Bedrocan produces medicinal-grade cannabis for the Dutch Ministry of Health under a framework agreement. The Dutch Office of Medicinal Cannabis supplies our products to a number of international governments that make medicinal cannabis available under special access conditions as an unapproved drug.